Gastroesophageal reflux and its clinical manifestation at gastroenteric and respiratory levels in childhood: Physiology, signs and symptoms, diagnosis and treatment

Expert Review of Respiratory Medicine

Volumn 1, Issue 3, 2007, Pages 391-401

  Sacco, Oliviero ^a   Mattioli, Girolamo ^a   Girosi, Donata ^a   Battistini, Elena ^a   Jasonni, Vincenzo ^a   Rossi, Giovanni A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

esophageal pH monitoring; gastroesophageal reflux; gastroesophageal reflux disease; multichannel intraluminal impedance; nissen fundoplication; proton pump inhibitors

Indexed keywords

EID: 77349105361     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.1.3.391     Document Type: Article

References (81)

1. Vandenplas Y, Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J. Pediatr. Gastroenterol. Nutr. 35 (2), 119–136 (2002).
2. Dent J, Dodds WJ, Friedman RH et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J. Clin. Invest. 65, 256–267 (1980).
3. Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence based consensus. Am. J. Gastroenterol. 101, 1900–1920 (2006).
4. Fonkalsrud EW, Ament ME. Gastroesophageal reflux in childhood. Curr. Probl. Surg. 33, 1–70 (1996).
5. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 109, 601–610 (1995).
6. Sifrim D, Holloway R. Transient lower esophageal sphincter relaxation: how many or how harmful? Am. J. Gastroenterol. 96, 2529–2532 (2001).
7. Hoffman I, Tertychnyy A, Ectors N, De Greef T, Haesendonck N, Tack J. Duodenogastro–esophageal reflux in children with refractory gastro–esophageal reflux disease. J. Pediatr. 151, 307–311 (2007).
8. Richter JE. Gastrooesophageal reflux disease. Best Pract. Res. Clin. Gastroenterol. 21, 609–631 (2007).
9. Kahrilas PJ. Upper esophageal sphincter function during antegrade and retrograde transit. Am. J. Med. 103 (5A), S56 –S60 (1997).
10. Carr MM, Poje CP, Ehrig D, Brodsky LS. Incidence of reflux in young children undergoing adenoidectomy. Laryngoscope 111, 2170–2172 (2001).
11. Boesch RP, Shah P, Vaynblat M et al. Relationship between upper airway obstruction and gastroesophageal reflux in a dog model. J. Invest. Surg. 18, 241–245 (2005).
12. Harding SM. Gastroesophageal reflux as an asthma trigger: acid stress. Chest 126, 1398–1399 (2004).
13. Nelson SP, Chen EH, Syniar GM, Christoffel KK; for the Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during infancy: a pediatric practice-based survey. Arch. Pediatr. Adolesc. Med. 151, 569–572 (1997).
14. Yellon RF, Goldberg H. Update on gastroesophageal reflux disease in pediatric airway disorders. Am. J. Med. 111 (8A), S78 –S84 (2001).
15. Osatakul S, Sriplung H, Puetapaiboon A, Junjana CO, Chamnongpakdi S. Prevalence and natural course of gastroesophageal reflux symptoms: a 1-year cohort study in Thai infants. J. Pediatr. Gastroenterol. Nutr. 34, 63–67 (2002).
16. Fleidher DR. Functional vomiting disorders in infancy: innocent vomiting, nervous vomiting, and infant rumination syndrome. J. Pediatr. 125 (6 Pt 2), S84 –S94 (1994).
17. Rudolph CD, Mazur LJ, Liptak GS et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children. Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 32 (Suppl. 2), S1 –S31 (2001).
18. Mathisen B, Worall L, Masel J, Wall C, Shepherd RW. Feeding problems in infants with gastro–oesophageal reflux disease: a controlled study. J. Pediatr. Child Health 35, 163–169 (1999).
19. Theodoropoulos DS, Flockey RF, Boyce HW Jr. Sandifer’s syndrome and gastro–oesophageal reflux disease. J. Neurol. Neurosurg. Psychiatr. 66, 805–806 (1999).
20. Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest 111, 1266–1272 (1997).
21. Boesch RP, Daines C, Willging JP et al. Advances in the diagnosis and management of chronic pulmonary aspiration in children. Eur. Respir. J. 28, 847–861 (2006).
22. Boyle JT. Gastroesophageal reflux disease in 2006: the imperfect diagnosis. Pediatr. Radiol. 36 (Suppl. 14), 192–195 (2006).
23. Colletti RB, Christie DL, Orenstein SR. Statement of the North American Society for Pediatric Gastroenterology and Nutrition. Indications for pediatric esophageal pH monitoring. J. Pediatr. Gastroenterol. Nutr. 21, 253–262 (1995).
24. Shay SS, Johnson LF, Richter JE. Acid rereflux: a review, emphasizing detection by impedance, manometry, and scintigraphy, and the impact on acid clearing pathophysiology as well as interpreting the pH record. Dig. Dis. Sci. 48, 1–9 (2003).
25. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111, 1192–1199 (1996).
26. Skopnik H, Silny J, Heiber O, Schulz J, Rau G, Heimann G. Gastroesophageal reflux in infants: evaluation of a new intraluminal impedance technique. J. Pediatr. Gastroenterol. Nutr. 23, 591–598 (1996).
27. Mattioli G, Pini-Prato A, Gentilino V et al. Esophageal impedance/pH monitoring in pediatric patients: preliminary experience with 50 cases. Dig. Dis. Sci. 51, 2341–2347 (2006)
28. Yellon RF, Coticchia J, Dixit S. Esophageal biopsy for the diagnosis of gastroesophageal reflux-associated otolaryngologic problems in children. Am. J. Med. 108 (Suppl. 4A), S131 –S138 (2000).
29. Rudolph CD. Supraesophageal complications of gastroesophageal reflux in children: challenges in diagnosis and treatment. Am. J. Med. 115 (Suppl. 3A), S150 –S156 (2003).
30. Shub MD, Ulshen MH, Hargrove CB et al. Esophagitis: a frequent consequence of gastroesophageal reflux in infancy. J. Pediatr. 107, 881–884 (1985).
31. Sacco O, Fregonese B, Silvestri M, Sabatini F, Mattioli G, Rossi GA. Bronchoalveolar lavage and esophageal pH monitoring data in children with “difficult to treat” respiratory symptoms. Pediatr. Pulmonol. 30, 313–319 (2000).
32. Colombo JL, Hallberg TK. Recurrent aspiration in children: lipid-laden alveolar macrophage quantitation. Pediatr. Pulmonol. 3, 86–89 (1987).
33. Bauer ML, Lyrene RK. Chronic aspiration in children: evaluation of the lipid-laden macrophage index. Pediatr. Pulmonol. 28, 94–100 (1999).
34. Knauer-Fischer S, Ratjen F. Lipid-laden macrophages in bronchoalveolar lavage fluid as a marker for pulmonary aspiration. Pediatr. Pulmonol. 27, 419–422 (1999).
35. Kazachkov MY, Muhlebach MS, Livasy CA, Noah TL. Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children. Eur. Respir. J. 18, 790–795 (2001).
36. Ahrens P, Noll C, Kitz R, Willigens P, Zielen S, Hofmann D. Lipid-laden alveolar macrophages (LLAM): a useful marker of silent aspiration in children. Pediatr. Pulmonol. 42, 452–457 (2007).
37. McVeagh P, Howman-Giles R, Kemp A. Pulmonary aspiration studied by radionuclide milk scanning and barium swallow roentgenography. Am. J. Dis. Child. 141, 917–921 (1987).
38. Fawcett HD, Hayden CK, Adams JC et al. How useful is gastroesophageal reflux scintigraphy in suspected childhood aspiration? Pediatr. Radiol. 18, 311–313 (1988).
39. Tutuian R, Castell DO. Classification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Gastroenterology 2, 230–239 (2004).
40. Nayar DS, Khandwala F, Achkar E et al. Esophageal manometry: assessment of interpreter consistency. Clin. Gastroenterol. Hepatol. 3, 218–224 (2005).
41. Hussain SZ, Di Lorenzo C. Motility disorders. Diagnosis and treatment for the pediatric patient. Pediatr. Clin. North Am. 49, 27–51 (2002).
42. 13C-octanoic acid breath test for measuring gastric emptying of solids. Eur. Rev. Med. Pharmacol. Sci. 9, 3–8 (2005).
43. Stipa F, Stein HJ, Feussner H, Kraemer S, Siewert JR. Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis. Esophagus 10, 24–28 (1997).
44. Kaltenback T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch. Intern. Med. 166, 965–971 (2006).
45. Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J. Pediatr. 146 (Suppl. 3), S3 –S12 (2005).
46. DeVault KR. Overview of medical therapy for gastroesophageal reflux disease. Gastroenterol. Clin. North Am. 28, 831–845 (1999).
47. Sandritter T. Gastroesophageal reflux disease in infants and children. J. Pediatr. Health Care 17, 198–205 (2003).
48. Sutphen JL, Dillard VL. Effect of ranitidine on twenty-four-hour gastric acidity in infants. J. Pediatr. 114, 472–474 (1989).
49. Simeone D, Caria MC, Miele E et al. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. J. Pediatr. Gastroenterol. Nutr. 25, 51–55 (1997).
50. 2 receptor antagonists have a therapeutic role in childhood? J. Pediatr. Gastroenterol. Nutr. 19, 270–276 (1994).
51. Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 118 (Suppl. 1), S9 –S31 (2000).
52. Cucchiara S, Minella R, Campanozzi A et al. Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood. Dig. Dis. Sci. 42, 293–299 (1997).
53. Hassall E, Israel D, Shepherd R et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J. Pediatr. 137, 800–807 (2000).
54. Andersson T, Hassall E, Lundborg P et al. Pharmacokinetics of orally administered omeprazole in children: International Pediatric Omeprazole Pharmacokinetic Group. Am. J. Gastroenterol. 95, 3101–3106 (2000).
55. Gunasekaran T, Gupta S, Gremse D et al. Lansoprazole in adolescents with gastroesophageal reflux disease. Pharmacokinetics, pharmacodynamics, symptom relief efficacy and tolerability. J. Pediatr. Gastroenterol. Nutr. 35 (Suppl. 4), S327 –S335 (2002).
56. Fiedorek S, Tolia V, Huang B, Stolle J, Lee C, Gremse D. Efficacy and safety of lansoprazole in adolescents with gastroesophageal reflux disease. J. Pediatr. Gastroenterol. Nutr. 40, 319–327 (2005).
57. Demirkan K, Bozkurt B, Karakaya G, Kalyoncu AF. Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. J. Invest. Allergol. Clin. Immunol. 16, 203–209 (2006).
58. Baldassarre E, Mendoza Sagaon M, Ferrarini A, Bianchetti MG. Severe systemic adverse reaction to proton pump inhibitors in an infant. Pediatr. Pulmonol. 42, 563–564 (2007).
59. Gralnek IM, Dulai GS, Fennerty MB, Spiegel BM. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin. Gastroenterol. Hepatol. 4, 1452–1458 (2006).
60. Iacono G, Carroccio A, Montalto G et al. Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux. Minerva Pediatr. 43, 797–800 (1991).
61. Tsou VM, Young RM, Hart MH, Vanderhoof JA. Elevated plasma aluminum levels in normal infants receiving antacids containing aluminum. Pediatrics 87, 148–151 (1991).
62. Poynard T, Vernisse B, Agostini H. Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro–oesophageal reflux. Aliment. Pharmacol. Ther. 12, 159–165 (1998).
63. Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur. J. Pediatr. 146, 156–158 (1987).
64. Reynolds JC, Putnam PE. Prokinetic agents. Gastroenterol. Clin. North Am. 21, 567–596 (1992).
65. Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic drug therapy in children: a review of current options. Ann. Pharmacother. 39, 706–711 (2005).
66. Ramirez B, Richter JE. Review article: promotility drugs in the treatment of gastro–oesophageal reflux disease. Aliment Pharmacol. Ther. 7, 5–20 (1993).
67. Shulman RJ, Boyle JT, Colletti RB et al.; North American Society for Pediatric Gastroenterology and Nutrition. An updated medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 31, 232–233 (2000).
68. Piche T, Galmiche JP, Pharmacological targets in gastro–oesophageal reflux disease. Basic Clin. Pharmacol. Toxicol. 97, 333–341 (2005).
69. Jolley SG, Herbst JJ, Johnson DG, Matlak ME, Book LS. Surgery in children with gastroesophageal reflux and respiratory symptoms. J. Pediatr. 96, 194–198 (1980).
70. Ahrens P, Heller K, Beyer P et al. Antireflux surgery in children suffering from reflux-associated respiratory diseases. Pediatr. Pulmonol. 28, 89–93 (1999).
71. Hassall E. Outcomes of fundoplication: causes for concern, newer options. Arch. Dis. Child. 90, 1047–1052 (2005).
72. Perdikis G, Hinder RA, Lund RJ et al. Laparoscopic Nissen fundoplication: where do we stand? Surg. Laparosc. Endosc. 7, 17–21 (1997).
73. Di Lorenzo C, Orenstein S. Fundoplication: friend or foe? J. Pediatr. Gastroenterol. Nutr. 34, 117–124 (2002).
74. Mathei J, Coosemans W, Nafteux P et al. Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients. Surg. Endosc. DOI: 10.1007/s00464-007-9578-0 (2007) (Epub ahead of print).
75. Mattioli G, Sacco O, Repetto P et al. Necessity for surgery in children with gastrooesophageal reflux and supraoesophageal symptoms. Eur. J. Pediatr. Surg. 14, 7–13 (2004).
76. Mattioli G, Bax K, Becmeur F et al. European multicenter survey on the laparoscopic treatment of gastroesophageal reflux in patients aged less than 12 months with supraesophageal symptoms. Surg. Endosc. 19 (10), 1309–1314 (2005).
77. Mattioli G, Sacco O, Gentilino V et al. Outcome of laparoscopic Nissen–Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms. Surg. Endosc. 18 (3), 463–465 (2004).
78. Holschneider P, Dubbers M, Engelskirchen R, Trompelt J, Holschneider AM. Results of the operative treatment of gastroesophageal reflux in childhood with particular focus on patients with oesophageal atresia. Eur. J. Pediatr. Surg. 17 (3), 163–175 (2007).
79. Esposito C, Langer JC, Schaarschmidt K et al. Laparoscopic antireflux procedures in the management of gastroesophageal reflux following esophageal atresia repair. J. Pediatr. Gastroenterol. Nutr. 40, 349–351 (2005).
80. Johnsson F, Holloway RH, Ireland AC, Jamieson GG, Dent J. Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux. Br. J. Surg. 84, 686–689 (1997).
81. Ngerncham M, Barnhart DC, Haricharan RN, Roseman JM, Georgeson KE, Harmon CM. Risk factors for recurrent gastroesophageal reflux disease after fundoplication in pediatric patients: a case–control study. J. Pediatr. Surg. 42 (9), 1478–1485 (2007).